COLLEGIUM PHARMACEUTICAL INC - NOTE 2.625% 2/1

Historical Holders from Q1 2020 to Q2 2024

Type / Class
Debt / NOTE 2.625% 2/1
All holders as of 30 Jun 2024
Q2 2024
Total 13F principal, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-7
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of COLLEGIUM PHARMACEUTICAL INC - NOTE 2.625% 2/1

Period Principal Value Change Price Investors
2024 Q2 0 $0 -$37,712,983 0
2024 Q1 26,605,000 $37,712,983 +$811,681 $1.43 7
2023 Q4 26,039,566 $32,510,998 +$5,639 $1.22 7
2023 Q3 26,039,566 $26,761,542 +$562 $1.02 7
2023 Q2 26,039,566 $26,440,939 +$1,014,900 $1.01 7
2023 Q1 25,019,566 $27,289,994 -$4,005,109,832 $1.07 7
2022 Q4 128,496,600 $128,197,104 +$1,882,461 $1.02 16
2022 Q3 130,974,100 $126,245,995 +$2,987,304 $0.8602 14
2022 Q2 129,811,600 $122,917,136 +$78,266 $0.8813 14
2022 Q1 131,944,000 $135,664,199 +$10,037,198 $0.9974 14
2021 Q4 121,963,000 $124,806,000 -$3,671,443 $0.9751 13
2021 Q3 129,026,000 $129,406,102 -$4,815,502 $0.9985 16
2021 Q2 133,276,000 $146,434,836 +$5,994,400 $1.09 17
2021 Q1 128,105,000 $139,876,013 +$3,002,668 $1.09 16
2020 Q4 125,635,000 $123,722,398 +$3,816,154 $0.9893 17
2020 Q3 121,703,417 $119,676,395 +$15,937,272 $0.988 19
2020 Q2 106,265,846 $95,906,878 +$4,664,417 $0.9017 20
2020 Q1 101,019,968 $91,467,945 +$91,467,945 $0.92 19